The design and execution of clinical trials in cardiology adhere to rigorous scientific and ethical standards. Large-scale trials often involve collaboration between multiple research centers and may span several years to gather robust and statistically significant data. Patient recruitment, informed consent, and adherence to strict protocols are fundamental aspects of conducting ethical clinical trials. The outcomes of these trials guide healthcare professionals in making evidence-based decisions about the adoption of new therapies, shaping clinical guidelines and influencing standards of care. As technology and understanding of cardiovascular diseases advance, clinical trials play a pivotal role in translating scientific discoveries into tangible benefits for patients, fostering innovation, and continuously improving the landscape of cardiology practice.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation